Literature DB >> 14575314

Effect of propranolol on cardiac cytokine expression after myocardial infarction in rats.

Alexander Deten1, Hans Christian Volz, Alexander Holzl, Wilfried Briest, Heinz-Gerd Zimmer.   

Abstract

The pro-inflammatory cytokines interleukin (IL)-1beta and IL-6 have been shown to be upregulated in the myocardium after injury and after adrenergic receptor stimulation. Together with other cytokines, such as the transforming growth factor (TGF)-beta, the pro-inflammatory cytokines have been implicated in the initiation of tissue repair and wound healing after myocardial infarction (MI). In the present study, the effect of beta-adrenergic receptor blockade with propranolol (2 mg/kg x h s.c. by miniosmotic pumps) on cardiac cytokine expression and on wound healing was analyzed in rats from 6-72 h after MI. IL-1beta and IL-6 gene expression strongly increased in the infarcted myocardium 6 h after MI and peaked after 12 h, while TGF-beta, progressively increased from 12 h onwards. Also, TGF-beta2 increased after 12 h, peaked after 24 h and declined thereafter, while TGF-beta, was only elevated after 72 h. Treatment with propranolol had a negative chronotropic effect throughout the observation period of 72 h. It attenuated the initial elevation in LVEDP and increased cardiac output ultimately. Furthermore, propranolol attenuated IL-1beta mRNA expression, but had not effect on the other cytokines. Moreover, MMP-9 gelatinolytic activity was markedly attenuated by propranolol indicating a delayed resorption of the necrotic tissue and, possibly, collagen turnover. Replacement by scar tissue, however, was not affected as indicated by normal collagen expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14575314

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  43 in total

Review 1.  Cytokines and the microcirculation in ischemia and reperfusion.

Authors:  N G Frangogiannis; K A Youker; R D Rossen; M Gwechenberger; M H Lindsey; L H Mendoza; L H Michael; C M Ballantyne; C W Smith; M L Entman
Journal:  J Mol Cell Cardiol       Date:  1998-12       Impact factor: 5.000

Review 2.  The role of interleukin-6 in the failing heart.

Authors:  K C Wollert; H Drexler
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

3.  Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice.

Authors:  L E Rohde; A Ducharme; L H Arroyo; M Aikawa; G H Sukhova; A Lopez-Anaya; K F McClure; P G Mitchell; P Libby; R T Lee
Journal:  Circulation       Date:  1999-06-15       Impact factor: 29.690

4.  Transforming growth factor beta 3 (TGF beta 3) accelerates wound healing without alteration of scar prominence. Histologic and competitive reverse-transcription-polymerase chain reaction studies.

Authors:  L Wu; A Siddiqui; D E Morris; D A Cox; S I Roth; T A Mustoe
Journal:  Arch Surg       Date:  1997-07

5.  beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling.

Authors:  S D Prabhu; B Chandrasekar; D R Murray; G L Freeman
Journal:  Circulation       Date:  2000-05-02       Impact factor: 29.690

6.  Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats.

Authors:  Alexander Deten; Hans Christian Volz; Wilfried Briest; Heinz-Gerd Zimmer
Journal:  Cardiovasc Res       Date:  2002-08-01       Impact factor: 10.787

7.  Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms.

Authors:  Y Zhang; K McCluskey; K Fujii; L M Wahl
Journal:  J Immunol       Date:  1998-09-15       Impact factor: 5.422

8.  Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions.

Authors:  M Gwechenberger; L H Mendoza; K A Youker; N G Frangogiannis; C W Smith; L H Michael; M L Entman
Journal:  Circulation       Date:  1999-02-02       Impact factor: 29.690

9.  IL-6 induces hepatic inflammation and collagen synthesis in vivo.

Authors:  I Choi; H S Kang; Y Yang; K H Pyun
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

10.  Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction.

Authors:  V Kaartinen; J W Voncken; C Shuler; D Warburton; D Bu; N Heisterkamp; J Groffen
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330

View more
  20 in total

Review 1.  Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction.

Authors:  Merry L Lindsey; Rogelio Zamilpa
Journal:  Cardiovasc Ther       Date:  2010-07-14       Impact factor: 3.023

Review 2.  Inflammatory response and cardioprotection during open-heart surgery: the importance of anaesthetics.

Authors:  M-S Suleiman; K Zacharowski; G D Angelini
Journal:  Br J Pharmacol       Date:  2007-10-22       Impact factor: 8.739

Review 3.  The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatases.

Authors:  A Rietz; Jp Spiers
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 4.  Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends?

Authors:  Melissa L Martin; Burns C Blaxall
Journal:  J Cardiovasc Transl Res       Date:  2012-09-27       Impact factor: 4.132

5.  S-propranolol protected H9C2 cells from ischemia/reperfusion-induced apoptosis via downregultion of RACK1 Gene.

Authors:  Xiongfei Jia; Li Zhang; Xiaoqin Mao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 6.  Translating Koch's postulates to identify matrix metalloproteinase roles in postmyocardial infarction remodeling: cardiac metalloproteinase actions (CarMA) postulates.

Authors:  Rugmani Padmanabhan Iyer; Lisandra E de Castro Brás; Yu-Fang Jin; Merry L Lindsey
Journal:  Circ Res       Date:  2014-02-28       Impact factor: 17.367

Review 7.  Matrix metalloproteinases: drug targets for myocardial infarction.

Authors:  Andriy Yabluchanskiy; Yaojun Li; Robert J Chilton; Merry L Lindsey
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

Review 8.  The immune system and cardiac repair.

Authors:  Nikolaos G Frangogiannis
Journal:  Pharmacol Res       Date:  2008-06-24       Impact factor: 7.658

9.  Activation of AP-1 contributes to the beta-adrenoceptor-mediated myocardial induction of interleukin-6.

Authors:  Susanne Rohrbach; Stefan Engelhardt; Martin J Lohse; Karl Werdan; Juergen Holtz; Ursula Muller-Werdan
Journal:  Mol Med       Date:  2007 Nov-Dec       Impact factor: 6.354

Review 10.  Understanding cardiac extracellular matrix remodeling to develop biomarkers of myocardial infarction outcomes.

Authors:  Signe Holm Nielsen; Alan J Mouton; Kristine Y DeLeon-Pennell; Federica Genovese; Morten Karsdal; Merry L Lindsey
Journal:  Matrix Biol       Date:  2017-12-14       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.